IVIEW Therapeutics Inc.   Report issue

For profit Phase 2
Founded: Doylestown PA United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2019
NCT03749317
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

IVIEW Therapeutics Inc.